1. Aleman B, van den Belt-Dusebout A, Klokman W, van't Veer M, Bartelink H, van Leeuwen F: Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol 21:3431, 2003.

2. Ng A, Bernardo M, Weller E, et al.: Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol 20:2101, 2002.

3. Radford J, Eardley A, Woodman C, Crowther D: Routine outpatient review following treatment for Hodgkin's disease and a efficient way of detecting relapse. Proc Am Soc Clin Oncol 14:86, 1995.

4. Dores G, Metayer C, Curtis R, et al.: Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol 20:3484-3494, 2002.

that may arise. A well-informed patient is more likely to seek medical attention with new symptoms. However, patient teaching must be done without causing excessive alarm or anxiety in the patient and their family members, and special attention must be paid to their psychosocial state. Routine physician visits by HL survivors are probably more valuable for the sense of comfort they provide to the patients than the detection of recurrent HL or treatment complications. During these visits, it is important to review and explain potential late complications of HL treatment, discuss the psychosocial impact of their disease, and promote health maintenance, including smoking cessation, cardiovascular risk reduction, and self-examination of skin and breast tissue. Although an occasional patient will present with asymptomatic physical or laboratory findings suspicious for recurrence or treatment-related complication, most of these will be detected in symptomatic patients who return for unscheduled visits.

Anxiety Away

Anxiety Away

The strategies revealed within Anxiety Away are fast acting, simple and guaranteed to work even if you have suffered from anxiety for a long time!

Get My Free Ebook

Post a comment